Lexicon Q1 ’17 Earnings Update
Here is a brief preview of this blast: Lexicon hosted its Q1 earnings call and provided updates to their T1DM and T2DM diabetes development programs for sotagliflozin and LX2761.
Here is a brief preview of this blast: Lexicon hosted its Q1 earnings call and provided updates to their T1DM and T2DM diabetes development programs for sotagliflozin and LX2761.